Successful pneumonectomy for invasive pulmonary aspergillosis and advanced non-small cell-lung cancer

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Minesaki, Shohei ^a   Koyama, Nobuyuki ^a,b   Ishida, Hironori ^a   Kobayashi, Kunihiko ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FUNGUS ANTIBODY; GAMMA GLUTAMYLTRANSFERASE; HYDROCORTISONE; MICAFUNGIN; SQUAMOUS CELL CARCINOMA ANTIGEN; VORICONAZOLE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; ASPERGILLUS; CANCER INVASION; CANCER STAGING; CASE REPORT; CHEMORADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DISEASE COURSE; DRUG TREATMENT FAILURE; ENZYME ACTIVITY; FEVER; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNGUS ISOLATION; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ASPERGILLOSIS; LUNG CAVITATION; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SCINTISCANNING; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION PNEUMONIA; SALVAGE THERAPY; SMOKING; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; TUMOR VOLUME;

EID: 84876514093     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-007925     Document Type: Article

References (15)

1. Morris G, Kokki MH, Anderson K, et al. Sampling of Aspergillus spores in air. J Hosp Infect 2000;44:81-92.
2. Ader F, Nseir S, Le Berre R, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005;11:427-9.
3. Berenguer J, Allende MC, Lee JW, et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone- induced immunosuppression. Am J Respir Crit Care Med 1995;152:1079-86.
4. Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007;127:349-55.
5. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.
6. Wong K, Waters CM, Walesby RK. Surgical management of invasive pulmonary aspergillosis in immunocompromised patients. Eur J Cardiothorac Surg 1992;6:138-42.
7. Matt P, Bernet F, Habicht J, et al. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia. Chest 2004;126:1783-8.
8. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
9. Matsuda T, Koreeda Y, Mataki H, et al. A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid. Intern Med 2010;49:1163-9.
10. Okamoto T, Koh K, Takita J, et al. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia. Pediatr Int 2010;52:137-41.
11. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-66.
12. Bulpa PA, Dive AM, Garrino MG, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive carě Intensive Care Med 2001;27:59-67.
13. Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;170:621-5.
14. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800.
15. Yan X, Li M, Jiang M, et al. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 2009;115:5018-25.